Skip to content
ABOUT
Company
Team
Board of Directors
Scientific Advisory Board
Advisors
Careers
PRODUCTS
PIPELINE
ExoPTEN
Spinal Cord Injury
Optic Nerve Injury
Road Map
PLATFORM
ExoTherapy
Exosomes
siRNA
Drug Delivery
Future Indications
Publications
Intellectual Property
COLLABORATIONS
INVESTORS
Stock Info
Financials & Filings
News
Events
Presentations
Analyst Coverage
Corporate Governance
MEDIA
Press Releases
Articles
Podcasts
Videos
ABOUT
Company
Team
Board of Directors
Scientific Advisory Board
Advisors
Careers
PRODUCTS
PIPELINE
ExoPTEN
Spinal Cord Injury
Optic Nerve Injury
Road Map
PLATFORM
ExoTherapy
Exosomes
siRNA
Drug Delivery
Future Indications
Publications
Intellectual Property
COLLABORATIONS
INVESTORS
Stock Info
Financials & Filings
News
Events
Presentations
Analyst Coverage
Corporate Governance
MEDIA
Press Releases
Articles
Podcasts
Videos
Exo-Top
Exo-Top
Home
Episode
A Nanodrug Drug Platform for Treating Acute Spinal Injuries – Life Sciences Today Podcast Episode 6
Podcast
A Nanodrug Drug Platform for Treating Acute Spinal Injuries – Life Sciences Today Podcast Episode 6
NurExone
A Nanodrug Drug Platform for Treating Acute Spinal Injuries - Life Sciences Today Podcast Episode 6
Play Episode
Pause Episode
1x
00:00
/
38:11
Subscribe
Share
RSS Feed
Share
Link
Embed
<blockquote class="wp-embedded-content" data-secret="PtscZ5iVIL"><a href="https://nurexone.com/podcast/a-nanodrug-drug-platform-for-treating-acute-spinal-injuries/">A Nanodrug Drug Platform for Treating Acute Spinal Injuries – Life Sciences Today Podcast Episode 6</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://nurexone.com/podcast/a-nanodrug-drug-platform-for-treating-acute-spinal-injuries/embed/#?secret=PtscZ5iVIL" width="500" height="350" title="“A Nanodrug Drug Platform for Treating Acute Spinal Injuries – Life Sciences Today Podcast Episode 6” — NurExone" data-secret="PtscZ5iVIL" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://nurexone.com/wp-includes/js/wp-embed.min.js </script>
Prev
Previous Episode
Changing the Glaucoma Paradigm?
Next Episode
Regenerative Spinal Cord Therapy
Next
Careers
Collaborations
Company
Contact Us
Data Room
Data Room old
Enerspar
Eran Ovadya
Events
Events
Exo-Top
EXOPTEN
EXOPTEN: CNSI
ExoPTEN: Facial Nerve Damage
ExoPTEN: Glaucoma
ExoTherapy
Healthcare
Home
In The Media
Ina Sarel
Investor Webinar, Oct 20, 2022
Investors
IP
Jacob Licht Business Card
Lior Shaltiel
Pipeline
Podcast
Press Releases
Privacy Policy
PTEN
Road Map
Science
Scientific Articles
siRNA Sequences
Team
TERMS & CONDITIONS
The Science of ExoPTEN
Transaction in the Exosome filed
Videos
Yoram Drucker
Set layout popup
